Work

How could gene therapy change the way we treat age-related macular degeneration?

Year: 2022
Type: editorial
Abstract: Age-related macular degeneration (AMD) is the leading cause of permanent vision loss in individuals over 50 years of age [1]. Advanced AMD can anatomically present as either neovascular (nAMD) or a...
Language: English
Subfield: Ophthalmology
Field: Medicine
Open Access status: bronze
OpenAlex ID: W4308971187
Cites: 11
Cited by: 3
Related to: 10